Tech Company Financing Transactions
Cognition Therapeutics Funding Round
Private investors participated in a $1.9 million funding round for Cognition Therapeutics. This venture round was announced by the company on 1/4/2013.
Transaction Overview
Company Name
Announced On
1/4/2013
Transaction Type
Debt
Amount
$1,921,749
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2403 Sidney St. 261
Pittsburgh, PA 15203
USA
Pittsburgh, PA 15203
USA
Phone
Website
Email Address
Overview
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimers disease and other neurodegenerative disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kenneth Moch
Chief Financial Officer
Stephen DiPalma
Chief Medical Officer
Gilbert Rishton
Chief Scientific Officer
Susan Catalano
Browse more venture capital transactions:
Prev: 1/4/2013: Room 77 venture capital transaction
Next: 1/4/2013: StudyBlue venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs